Functionally validate ATP2A2 as a drug target in disease models (e.g., heart failure, Alzheimer's) by measuring expression and activity changes in response to genetic or pharmacological modulation.
Unlocking Precision in Calcium Signaling Research - Accelerate Your Target Validation with Confidence!
Are you currently facing challenges in elucidating the role of SERCA2 dysfunction in disease pathogenesis, hindered by inconsistent protein expression or a lack of robust functional assays? Our ATP2A2 Analysis Services leverage advanced molecular biology and cellular phenotyping platforms to help you dissect the complex biology of the SERCA2 pump, providing the critical data needed to validate novel therapeutic targets and diagnostic biomarkers.
Dysregulation of intracellular calcium homeostasis, often mediated by the Sarco/Endoplasmic Reticulum Calcium ATPase 2 (SERCA2, encoded by ATP2A2), is a pivotal factor in numerous pathologies from cardiovascular diseases to neurological disorders and dermatological conditions like Darier disease. Reliable analysis of ATP2A2 expression, localization, and function is therefore non-negotiable for credible research and therapeutic development. Our service provides a comprehensive, orthogonal approach to overcome the technical hurdles associated with this critical membrane protein.
| Technical Method | Core Principle | Primary Application in ATP2A2 Analysis |
|---|---|---|
| qPCR / Digital PCR | Quantitative nucleic acid amplification | Precise measurement of ATP2A2 mRNA expression levels and splice variants. |
| Immunoblotting & ELISA | Protein detection via antibody binding | Semi-quantitative and quantitative analysis of SERCA2 protein expression and isoform profiling. |
| IF/ IHC | Antibody-based spatial detection | Subcellular localization of SERCA2 in fixed cells or tissue sections. |
| Functional Calcium Assays | Fluorometric detection of Ca²⁺ flux | Direct measurement of SERCA2 pump activity and calcium reuptake kinetics in live cells. |
| Gene Editing Validation | Sequencing & functional phenotyping | Confirmation of ATP2A2 knockout/knockdown and assessment of downstream phenotypic consequences. |
Fig.1 ATP2A2 facilitates delivery of nucleotide sugars to the mammalian Golgi.1
We deliver more than just data points; we provide a molecular narrative for your ATP2A2-related research. Our service translates your samples into a clear profile of gene expression, protein dynamics, and functional competency of the SERCA2 pump. We help you answer critical questions: Is the observed phenotype linked to altered ATP2A2 transcription or protein stability? Does a candidate compound effectively rescue SERCA2 function? Our reports are designed to deliver actionable insights for your next experimental or development phase.
Discover the Depth of Our Analysis – Request a Project Consultation!
Our process is designed for transparency, rigor, and to maximize the value of your valuable samples.
We begin with a detailed consultation to define your objectives. You provide the starting materials (e.g., cell lysates, RNA samples, fixed tissue sections, or live cells). We perform initial quality control to ensure sample integrity.
Our scientists design a tailored analysis plan, selecting the most appropriate combination of platforms from our portfolio to address your specific hypotheses about ATPA2A2 biology.
We conduct the agreed-upon analyses in parallel or sequence. This may include nucleic acid extraction and qPCR, protein quantification and immunoblotting, and/or setup of live-cell calcium imaging experiments.
Raw data from each platform are rigorously analyzed. Our experts correlate findings across methods, for example, linking mRNA expression changes with protein levels and functional output.
You receive a final deliverable that includes not just raw data and standard graphs (e.g., amplification plots, western blot images, calcium trace curves), but also a synthesized interpretation discussing the implications of the multi-parametric results for your research goals.
Functionally validate ATP2A2 as a drug target in disease models (e.g., heart failure, Alzheimer's) by measuring expression and activity changes in response to genetic or pharmacological modulation.
Investigate the molecular pathology of Darier disease and other SERCA2-related disorders by profiling mutant vs. wild-type protein expression, localization, and pump dysfunction.
Identify and quantify ATP2A2 mRNA or protein isoforms in patient samples as potential diagnostic or prognostic biomarkers for conditions involving ER stress and calcium dysregulation.
Assess the efficacy of novel SERCA2 activators or stabilizers by measuring their impact on calcium reuptake kinetics and SERCA2 protein homeostasis in relevant cellular systems.
Accurately characterize the SERCA2 status (expression, function) in engineered cell lines (e.g., knockouts) or primary cells used for your research, ensuring model validity.
Fig.2 Result of double immunohistochemical stainings of ITPR1 and ATXN2.2
A study investigating cerebellar ataxia utilized ATP2A2 analysis to pinpoint mechanistic insights. Researchers employed a combination of qPCR and immunofluorescence to demonstrate significant downregulation and mislocalization of the SERCA2 protein in Purkinje cells within a disease model. This multi-faceted analysis directly linked the observed calcium dyshomeostasis and neuronal vulnerability to a specific deficit in SERCA2-mediated calcium clearance, highlighting the pump's critical role in neuronal health and validating it as a key point of investigation in neurodegenerative processes.
Leverage the Creative Biolabs Advantage – Reach Out for a Tailored Quote Today.
A: Expression data (qPCR/Western) tells you if SERCA2 is present, but a functional assay tells you how well it is working. Measuring calcium reuptake kinetics is the ultimate readout of pump activity and is essential for studying inhibitors, activators, or disease-causing mutations.
A: Yes. We have optimized RNA and protein extraction protocols for FFPE tissues, allowing for qPCR and immunohistochemical analysis of ATP2A2 in archived patient samples, which is invaluable for translational biomarker studies.
A: While the core analysis service focuses on characterization, we can partner with you or refer you to our dedicated cell line engineering team to generate knockout, knockdown, or mutant ATP2A2 cell models for subsequent analysis.
A: We use isoform-specific primers for qPCR and rigorously validated antibodies for protein detection. Our assay design includes controls to confirm the specificity of the signal for the SERCA2a (cardiac/muscle) or SERCA2b (ubiquitous) isoforms.
A: We are flexible. Minimum requirements depend on the assay panel but typically start at 1 µg of high-quality total RNA for qPCR or 50 µg of total protein for immunoblotting. We provide detailed guidelines upon project consultation.
| Cat | Service |
| BAS92-1 | ATP2A2 Protein Analysis |
| BAS92-2 | ATP2A2 Isoform Analysis |
| BAS92-3 | ATP2A2 Mutation Analysis |
Creative Biolabs stands as your dedicated partner for precise and insightful ATP2A2 Analysis. Our comprehensive service suite, from molecular profiling to functional phenotyping, is designed to deliver the critical data you need to advance your research in calcium signaling and related diseases. Ready to gain clarity on SERCA2 in your research model? Contact our scientific team to discuss your specific project needs and receive a detailed service plan.
References
For Research Use Only.